Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.71783 | 73 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.5822 | 72 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.42422 | 71 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.55946 | 71 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.53505 | 72 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.44165 | 80 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.36779 | 70 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.56581 | 72 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.42501 | 71 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.57914 | 72 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.59945 | 72 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.57902 | 72 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.79804 | 74 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.59964 | 72 |